BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25111083)

  • 1. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
    Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
    AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
    Shmagel KV; Saidakova EV; Shmagel NG; Korolevskaya LB; Chereshnev VA; Robinson J; Grivel JC; Douek DC; Margolis L; Anthony DD; Lederman MM
    HIV Med; 2016 Sep; 17(8):581-9. PubMed ID: 27187749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
    Taye S; Lakew M
    BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    Kuniholm MH; OʼBrien TR; Prokunina-Olsson L; Augenbraun M; Plankey M; Karim R; Sarkar M; French AL; Pierce C; Strickler HD; Anastos K
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):162-70. PubMed ID: 27183178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
    Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
    Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients.
    Harcourt G; Gomperts E; Donfield S; Klenerman P
    Gut; 2006 Oct; 55(10):1484-7. PubMed ID: 16543291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.
    Kang F; Chen W; Zhang X; Nie W; Fu J; Xu X; Zhao P; Zhang X; Li W; Wang FS; Zhang Z; Zhao M
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):135-42. PubMed ID: 23075912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.
    Zhuang Y; Wei X; Li Y; Zhao K; Zhang J; Kang W; Sun Y
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1044-51. PubMed ID: 22214236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.
    Körner C; Krämer B; Schulte D; Coenen M; Mauss S; Fätkenheuer G; Oldenburg J; Nattermann J; Rockstroh JK; Spengler U
    Clin Sci (Lond); 2009 May; 116(12):861-70. PubMed ID: 19128241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    Rallón N; García M; García-Samaniego J; Rodríguez N; Cabello A; Restrepo C; Álvarez B; García R; Górgolas M; Benito JM
    PLoS One; 2017; 12(3):e0173943. PubMed ID: 28323897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
    Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
    Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection.
    Saha B; Choudhary MC; Sarin SK
    AIDS; 2013 Sep; 27(14):2191-200. PubMed ID: 23820090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy.
    Sede M; Parra M; Manrique JM; Laufer N; Jones LR; Quarleri J
    Infect Genet Evol; 2016 Sep; 43():186-96. PubMed ID: 27234841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
    Villacres MC; Kono N; Mack WJ; Nowicki MJ; Anastos K; Augenbraun M; Liu C; Landay A; Greenblatt RM; Gange SJ; Levine AM
    J Infect Dis; 2012 Sep; 206(5):780-9. PubMed ID: 22693231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
    de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
    Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.